IndiaTickerDr Reddys Laboratories Ltd - 500124 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015- Conference Call TranscriptBSE · conference call · 13 pages
VerifiedArchived copy Company dossier
Dr Reddys Laboratories
NSE:DRREDDY · ISIN INE089A01031
- Close
- ₹1,142.3 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Dr Reddys Laboratories
Business
Business evidence pack
Source documentsPrimary material for understanding Dr Reddys Laboratories
Business-model synthesis will be generated from the company's annual reports, investor presentations and conference-call material. Until that layer is reconciled, IndiaTicker shows the source pack instead of company-specific claims.
General Updates - Dr. Reddy's Laboratories LimitedNSE · conference call · 13 pages
VerifiedArchived copy Dr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · conference call · 2 pages
VerifiedArchived copy Updates - Dr. Reddy's Laboratories LimitedNSE · annual report · 2 pages
VerifiedArchived copy General Updates - Dr. Reddy's Laboratories LimitedNSE · annual report · 285 pages
VerifiedArchived copy Dr Reddys Laboratories Ltd - 500124 - Reg. 34 (1) Annual Report.BSE · annual report · 285 pages
VerifiedArchived copy Dr Reddys Laboratories Ltd - 500124 - Letter To Shareholders In Relation To Integrated Annual Report Of The Company For FY 2025-26BSE · annual report · 2 pages
VerifiedArchived copy Dr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015BSE · annual report · 1 pages
VerifiedArchived copy General Updates - Dr. Reddy's Laboratories LimitedNSE · annual report · 1 pages
VerifiedArchived copy General Updates - Dr. Reddy's Laboratories LimitedNSE · annual report · 1 pages
VerifiedArchived copy